Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1993 1
2000 1
2003 1
2005 2
2006 4
2007 4
2009 2
2010 5
2011 2
2012 8
2013 5
2014 4
2015 10
2016 15
2017 10
2018 13
2019 16
2020 18
2021 20
2022 16
2023 14
2024 23
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches.
Sheibani M, Azizi Y, Shayan M, Nezamoleslami S, Eslami F, Farjoo MH, Dehpour AR. Sheibani M, et al. Cardiovasc Toxicol. 2022 Apr;22(4):292-310. doi: 10.1007/s12012-022-09721-1. Epub 2022 Jan 21. Cardiovasc Toxicol. 2022. PMID: 35061218 Review.
Doxorubicin is an effective chemotherapeutic agent prescribed to treat solid tumors (e.g., ovary, breast, and gastrointestinal cancers). This anti-cancer drug has various side effects, such as allergic reactions, cardiac damage, hair loss, bone marrow suppression, vomiting …
Doxorubicin is an effective chemotherapeutic agent prescribed to treat solid tumors (e.g., ovary, breast, and gastrointestinal cancer …
Explaining the black-box smoothly-A counterfactual approach.
Singla S, Eslami M, Pollack B, Wallace S, Batmanghelich K. Singla S, et al. Med Image Anal. 2023 Feb;84:102721. doi: 10.1016/j.media.2022.102721. Epub 2022 Dec 13. Med Image Anal. 2023. PMID: 36571975 Free PMC article.
We propose a BlackBox Counterfactual Explainer, designed to explain image classification models for medical applications. Classical approaches (e.g., , saliency maps) that assess feature importance do not explain how imaging features in important anatomical regions are rel …
We propose a BlackBox Counterfactual Explainer, designed to explain image classification models for medical applications. Classical approach …
Worldwide Survey of COVID-19-Associated Arrhythmias.
Coromilas EJ, Kochav S, Goldenthal I, Biviano A, Garan H, Goldbarg S, Kim JH, Yeo I, Tracy C, Ayanian S, Akar J, Singh A, Jain S, Zimerman L, Pimentel M, Osswald S, Twerenbold R, Schaerli N, Crotti L, Fabbri D, Parati G, Li Y, Atienza F, Zatarain E, Tse G, Leung KSK, Guevara-Valdivia ME, Rivera-Santiago CA, Soejima K, De Filippo P, Ferrari P, Malanchini G, Kanagaratnam P, Khawaja S, Mikhail GW, Scanavacca M, Abrahão Hajjar L, Rizerio B, Sacilotto L, Mollazadeh R, Eslami M, Laleh Far V, Mattioli AV, Boriani G, Migliore F, Cipriani A, Donato F, Compagnucci P, Casella M, Dello Russo A, Coromilas J, Aboyme A, O'Brien CG, Rodriguez F, Wang PJ, Naniwadekar A, Moey M, Kow CS, Cheah WK, Auricchio A, Conte G, Hwang J, Han S, Lazzerini PE, Franchi F, Santoro A, Capecchi PL, Joglar JA, Rosenblatt AG, Zardini M, Bricoli S, Bonura R, Echarte-Morales J, Benito-González T, Minguito-Carazo C, Fernández-Vázquez F, Wan EY. Coromilas EJ, et al. Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009458. doi: 10.1161/CIRCEP.120.009458. Epub 2021 Feb 7. Circ Arrhythm Electrophysiol. 2021. PMID: 33554620 Free PMC article.
Engineered Silver Nanoparticles, A New Nanoweapon Against Cancer.
Ebrahimzadeh MA, Tafazoli A, Akhtari J, Biparva P, Eslami S. Ebrahimzadeh MA, et al. Anticancer Agents Med Chem. 2018;18(14):1962-1969. doi: 10.2174/1871520618666180808093040. Anticancer Agents Med Chem. 2018. PMID: 30088451 Review.
Using distinctive properties of this approach, i.e. as green synthesized silver nanoparticles (G-AgNPs), in order to raise potential therapeutic efficacy, even up to two-fold higher than cis-platin, is going to play a crucial role in cancer treatment and could be considere …
Using distinctive properties of this approach, i.e. as green synthesized silver nanoparticles (G-AgNPs), in order to raise potential …
FAS-670A>G gene polymorphism and the risk of allograft rejection after organ transplantation: a systematic review and meta-analysis.
Eslami MM, Rezaei R, Abdollahi S, Davari A, Ahmadvand M. Eslami MM, et al. Blood Res. 2021 Mar 31;56(1):17-25. doi: 10.5045/br.2021.2020201. Blood Res. 2021. PMID: 33707352 Free PMC article. Review.
All eligible studies reporting the association between FAS-670A>G polymorphism and the risk of allograft rejection published up to December 2019 were extracted using a comprehensive systematic database search in the Web of Science, Scopus, and PubMed. ...Moreover, subgr …
All eligible studies reporting the association between FAS-670A>G polymorphism and the risk of allograft rejection published up to …
Novel therapeutic approaches for non-small cell lung cancer: an updated view.
Orooji N, Babaei S, Fadaee M, Abbasi-Kenarsari H, Eslami M, Kazemi T, Yousefi B. Orooji N, et al. J Drug Target. 2025 Apr 14:1-16. doi: 10.1080/1061186X.2025.2489986. Online ahead of print. J Drug Target. 2025. PMID: 40186594 Review.
This review explores emerging therapies, including targeted therapies such as tyrosine kinase inhibitors (TKIs) for actionable mutations (e.g., EGFR, ALK, ROS1), as well as the role of immune checkpoint inhibitors (ICIs) that employ the body's immune system to combat cance …
This review explores emerging therapies, including targeted therapies such as tyrosine kinase inhibitors (TKIs) for actionable mutations (e. …
179 results